May 14, 2012

Welcome Molecules to Medicine the newest blog at #SciAmBlogs

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American

I am very excited to announce the latest addition to the #SciAmBlogs network - Molecules to Medicine, by Dr. Judy Stone.

Judy Stone, MD is an infectious disease specialist, experienced in conducting clinical research. She is the author of Conducting Clinical Research, the essential guide to the topic. As she says, 'she survived 25 years in solo practice in rural Cumberland, Maryland, and is now broadening her horizons. She particularly loves writing about ethical issues, and tilting at windmills in her advocacy for social justice. As part of her overall desire to save the world when she grows up, she has become especially interested in neglected tropical diseases. When not slaving over hot patients, she can be found playing with photography, friends’ dogs, or in her garden.'

You can check out many years' worth of archives on her old blog Politics, Science, and Other Assorted Musings, or follow her on Twitter @drjudystone.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

If you are a regular reader of the Scientific American Guest Blog, you have probably read several of Dr.Stone's previous posts:

Molecules to Medicine: Clinical Trials for Beginners

Molecules to Medicine: From Test-Tube to Medicine Chest

Lilly’s Shocker, or the Post-Marketing Blues

Molecules to Medicine: Pharma Trumps HIPAA?

Molecules to Medicine: Should pepper spray be put on (clinical) trial?

Molecules to Medicine: FDA at a Crossroads—a Tough Place to Be

Molecules to Medicine: Plan B: The Tradition of Politics at the FDA

Molecules to Medicine: “Conscience” Clauses versus Refusal: An Historical Perspective

Molecules to Medicine: When Religion Collides with Medical Care: Who Decides What Is Right for You?

A Taste of #TEDMED 2012: Appetizers

A Taste of #TEDMED 2012: Main Course

Molecules to Medicine: Have You Thanked a Clinical Researcher Today?

Molecules to Medicine: Public Health or Impaired Penises?

Now go and say Hi to Judy in the comments on her first post, then subscribe to or bookmark her blog so you don’t miss the future posts.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American